Spinex
Los Angeles
About Spinex
SpineX develops neuromodulatory tools and rehab devices for patients with unmet medical needs. They use rigorously tested neuromodulation technologies to aid recovery and restoration of bladder, bowel, respiration, sexual, and sensorimotor function for individuals with strokes, spinal cord injuries, multiple sclerosis, traumatic brain injuries, cerebral palsy, and other neurological conditions. The SCiP device is a non-invasive spinal cord neuromodulation device to treat the underlying neurological dysfunction related to cerebral palsy.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $255.6K
- Last round: Grant (Sep 2023)
- Website: spinexmed.com
- Phone: [email protected]
Industries & Categories
Clinical Trials, Medical, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/spinex-110669 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.